CervoMed News & Analysis

H.C. Wainwright Reiterates Buy on CervoMed Stock

H.C. Wainwright, an investment firm, has reiterated a Buy rating on CervoMed stock following the announcement of a new formulation. This indicates the firm's continued confidence in CervoMed's prospects and suggests potential growth due to the new product development.